← Back to Search

Diagnostic Test

measurements to evaluate metabolic bone disease for Skeletal Anomalies

N/A

Waitlist Available

Led By Renata Belfort de Aguiar, Phd,MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

Study Summary

This trial will study whether a more uniform and rigorous evaluation of bone and mineral homeostasis in kidney transplant recipients will result in better clinical outcomes.

Eligible Conditions

Skeletal Anomalies
Kidney Complication

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body Weight Changes

Secondary outcome measures

Variance in bone loss

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Rigorous evaluationExperimental Treatment1 Intervention

Participants will be evaluated for the rigorous evaluation received.

Group II: Standard careActive Control1 Intervention

The participants will be evaluated for the standard of care received.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

measurements to evaluate metabolic bone disease

2018

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,737,660 Total Patients Enrolled

Renata Belfort de Aguiar, Phd,MDPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to join this medical experiment?

"This trial is open to 25 persons between the ages of 30 and 65 who present with bone-related illnesses. Additionally, kidney transplant recipients within 3 months post surgery (intervention cohort) or 18 months after surgery (control cohort) may also apply."

Answered by AI

Does this research allow for participants who have surpassed the age of 35?

"As outlined in the study's selection criteria, only those between 30 and 65 years of age will be eligible for enrollment."

Answered by AI

How many individuals have been inducted into the trial thus far?

"Affirmative. The information available on clinicaltrials.gov indicates that the trial is actively searching for suitable candidates, with an initial posting date of December 12th 2018 and a last updated time of December 16th 2021. 25 patients are needed at 1 site to complete the study."

Answered by AI

Is enrollment currently open for this experiment?

"Per information on clinicaltrials.gov, this investigation is currently seeking participants; it was first published on December 12th 2018 and most recently updated in December 16 2021."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

2018. "Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03958409.